Asia Pacific Cell Culture Media Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.32 Billion |
 Market Size (Forecast Year) |
USD 3.44 Billion |
 CAGR |
% |
| Major Markets Players |
亚太细胞培养基市场细分，按类型（化学定义培养基、经典培养基、无血清培养基、特殊培养基、干细胞培养基、溶源性肉汤 (LB)、定制培养基配方等）、应用（生物制药生产、药物筛选与开发、诊断、再生医学与组织工程等）、最终用户（生物制药公司、生物技术组织、学术和研究实验室、医院、诊断中心、细胞库、法医实验室等）、分销渠道（直接招标、第三方分销和零售销售）– 行业趋势与预测至 2031 年
细胞培养基市场分析
细胞培养基市场分析涉及评估细胞培养基市场的全球和区域趋势、主要参与者、增长因素、挑战和新兴机会。细胞培养基对于实验室中细胞的生长和维持至关重要，在生物制药生产、学术研究、药物发现和再生医学等领域也必不可少。此外，研发支出的增加和疫苗产量的增加推动了市场的增长。
细胞培养基市场规模
2023 年亚太细胞培养基市场规模价值 13.2 亿美元，预计到 2031 年将达到 34.4 亿美元，2024 年至 2031 年预测期内的复合年增长率为 12.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括进出口分析、生产能力概览、生产消费分析、价格趋势分析、气候变化情景、供应链分析、价值链分析、原材料/消耗品概览、供应商选择标准、PESTLE 分析、波特分析和监管框架。
细胞培养基市场趋势
“生物制药项目研发支出增加”
生物制药项目研发支出的增加推动了全球细胞培养基市场的增长。生物制药公司正在大力投资研发新的治疗方法和疗法，这需要使用高质量的细胞培养基来支持生物产品的生长和测试。因此，由于生物制药公司需要先进的细胞培养基来支持其研发活动，对细胞培养基的需求正在增加。例如，根据《经济时报》发表的一篇文章，2024 年 7 月，卫生和家庭福利部拨款的修订估计显示，与 2022-23 年的修订估计相比，拨款增加了约 1.73%。这样做的目的是开发高价值的新药、生物制药和生物仿制药，这些都需要大量的研发工作。开发新的生物产品，如单克隆抗体、疫苗和基因疗法，需要使用先进的细胞培养基。这些产品需要特定的生长条件，例如温度、pH 值和营养水平，这些条件在体外很难复制。能够支持这些生物产品生长和测试的先进细胞培养基正在推动对专用细胞培养基的需求。
报告范围和细胞培养基市场细分
|
属性 |
细胞培养基关键市场洞察 |
|
涵盖的领域 |
|
|
覆盖国家 |
中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾和亚太地区其他地区 |
|
主要市场参与者 |
赛默飞世尔科技公司（美国）、默克公司（MilliporeSigma）（德国）、丹纳赫公司（Cytiva）（美国）、龙沙公司（瑞士）、赛多利斯公司（德国）、Bio-Rad Laboratories, Inc.（美国）、康宁公司（美国）、通用电气医疗集团（美国）、BD（碧迪公司）（美国）、Himedia Laboratories（印度）、Promocell（德国）、Sera Scandia A/S（丹麦）、VWR International, LLC（美国）、Elex Biological Products (Shanghai) Co., Ltd.（中国）、Vitro Diagnostics Inc.（美国）、Stemcell Technologies, Inc.（加拿大）、Caisson Labs Inc.（美国）、高进生物株式会社（韩国）、InvivoGen（美国）、富士胶片控股美国公司（美国）和 Takara Bio Inc.（日本）等 |
|
市场机会 |
|
|
增值数据信息集 |
除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解之外，Data Bridge Market Research 策划的市场报告还包括进出口分析、生产能力概览、生产消费分析、价格趋势分析、气候变化情景、供应链分析、价值链分析、原材料/消耗品概览、供应商选择标准、PESTLE 分析、波特分析和监管框架。 |
细胞培养基 市场定义
细胞 培养基是指对用于体外培养细胞的培养基的成分、质量和性能进行检查和评估。细胞培养基为细胞的生长和功能提供必需的营养、生长因子、激素和适当的环境。分析这种培养基对于生物技术、制药和生物医学研究等各个领域都至关重要。
细胞培养基市场动态
驱动程序
- 更加注重个性化医疗
对个性化医疗的日益关注推动了全球细胞培养基市场的增长。通过个性化医疗，患者可以根据其独特的基因图谱和疾病特征获得定制的治疗方案。这需要使用能够支持特定细胞或细胞类型生长的高质量细胞培养基，从而推动对专用细胞培养基的需求。例如，2023 年 3 月，根据美国国家医学图书馆的一篇文章，新技术的发展加速了个性化医疗的发展。个性化医疗的好处包括提高诊断准确性、减少副作用、更好地预防疾病，最重要的是，增加患者参与度、降低医疗成本，并促进研究和创新。
- 细胞治疗和再生医学的进展
细胞疗法和再生医学的进步正在推动全球细胞培养基市场的增长。细胞疗法涉及使用干细胞等细胞来治疗或预防疾病。再生医学旨在修复或替换受损的组织、器官或细胞。这两个领域都需要使用高质量的细胞培养基来支持细胞的生长和分化，这推动了对专用细胞培养基的需求。例如，根据美国国家医学图书馆发表的一篇文章，2023 年 8 月，干细胞疗法继续取得进展，为治愈无法治愈的疾病带来了希望。此外，干细胞可以被改变以提供强大的药物或纳米材料，并具有调节免疫系统的能力
机会
- 加强合作与伙伴关系
生物制药公司与学术研究机构之间的战略合作伙伴关系对于推动培养基配方创新变得越来越重要，尤其是针对特定研究和临床要求的培养基配方创新。这些合作可以汇集专业知识、资源和技术，加速开发新的和改进的配方。学术机构贡献尖端研究和知识，而生物制药公司则提供商业洞察力、制造能力和监管专业知识。例如，根据《科学家》杂志发表的一篇文章，2023 年 9 月，Cell Culture Collective, Inc. 很高兴宣布与 Defined Bioscience 建立战略合作伙伴关系。作为此次合作的一部分，Cell Culture Collective 将担任 Defined Bioscience 优化的动物和无血清干细胞培养产品的授权经销商。
- 生物制药和疫苗需求增加
由于医疗保健需求不断增长、人口不断增长以及对先进医疗治疗的认识不断提高，亚太、南美和中东等新兴地区对生物制药和疫苗的需求不断增加。这种激增为培养基制造商扩大其在这些地区的业务创造了重要机会。随着生物制药和疫苗生产规模扩大以满足当地需求，培养基制造商可以提供细胞培养、疫苗生产和治疗开发所需的关键成分，从而扩大其市场范围。销售和研发支出的快速增长凸显了对生物制药和疫苗的需求不断增长，为全球细胞培养基市场提供了重大机遇，因为生产和研究的增加将推动对专业培养基配方的需求。例如，根据 Medium 发表的一篇文章，2024 年 6 月，随着全球对创新疫苗的需求不断增长，制药公司正转向亚太地区，因为该地区人口众多且医疗保健意识不断增强。新兴的亚太国家也为针对地方性传染病的疫苗提供了巨大的潜力
限制/挑战
- 培养基配方的复杂性
开发能够支持多种细胞系的培养基，特别是用于高度专业化的应用，例如 CAR T 细胞疗法、神经干细胞研究和胚胎干细胞，需要大量的科学专业知识。每种细胞类型都有不同的营养、环境和生理要求，因此很难创建一刀切的培养基配方。开发过程需要大量的研究、优化和测试，以确保培养基能够支持细胞生长、分化和有效运作，这增加了制造过程的复杂性。例如，根据 BioPharma International 发表的一篇文章，2024 年 6 月，细胞依赖各种化学物质和材料来保持健康和功能。对于生物制药制造，这些细胞必须以高产量和高质量表达目标产品。基本成分包括用于能量的葡萄糖和碳基糖、用于蛋白质生产的氨基酸和肽、作为酶辅因子的维生素、用于细胞膜构建的脂质、用于渗透平衡的盐和用于酶功能的微量元素。所需培养基成分的复杂性说明了全球细胞培养市场在培养基配方方面面临的挑战，因为开发有效且定制的培养基需要了解不同细胞类型的特定需求。
- 生产成本高
高昂的生产成本是全球细胞培养基市场的一个重大制约因素。细胞培养基的生产过程涉及复杂的配方、高质量的原材料以及严格的测试和质量控制措施，这可能会推高成本。此外，生产过程可能需要专门的设备和设施，这也会导致更高的生产成本。因此，细胞培养基市场的制造商在保持盈利能力的同时满足客户对高质量产品的需求方面面临着重大挑战。高昂的生产成本对于规模较小的生物制药公司和研究机构来说尤其具有挑战性，因为它们可能不具备与大公司相同的规模经济。这些组织可能难以负担其研发活动所需的高质量细胞培养基，这可能会阻碍他们推进研发项目的能力。高昂的生产成本还会限制先进细胞培养基技术的采用，从而减缓新生物产品和疗法的开发。
细胞培养基市场范围
市场根据类型、应用、销售渠道、材料、滚筒直径、滚筒宽度和农业规模进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 化学成分确定的培养基
- 古典媒体
- 无血清培养基
- CHO 媒体
- HEK 293 培养基
- CAR-T 细胞培养基
- VERO 细胞培养基
- BHK媒体
- 昆虫细胞培养基
- 无血清细胞培养基
- 其他无血清培养基
- 专业媒体
- 干细胞培养基
- 间充质干细胞（MSCS）
- 神经干细胞（NSCS）
- 胚胎干细胞（ESCS）
- 骨髓
- 其他的
- 溶源肉汤 (LB)
- 定制培养基配方
- 其他的
应用
- 生物制药生产
- 单克隆抗体
- 疫苗生产
- 其他的
- 药物筛选与开发
- 诊断
- 再生医学与组织工程
- 干细胞和基因治疗
- 其他的
- 其他的
最终用户
- 生物制药公司
- 生物技术组织
- 学术及研究实验室
- 医院
- 诊断中心
- 细胞库
- 法医实验室
- 其他的
分销渠道
- 直接招标
- 第三方分销
- 零售销售
细胞培养基市场区域分析
对市场进行分析，并按上述国家、类型、应用、最终用户和分销渠道提供市场规模洞察和趋势。
市场覆盖的国家包括中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾和亚太其他地区。
由于研发技术的进步、主要参与者的存在以及研发支出的激增，中国成为亚太细胞培养基市场主导和增长最快的国家。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
细胞培养基市场份额
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
在市场上运营的细胞培养基市场领导者是：
- 赛默飞世尔科技公司（美国）
- 默克公司（MilliporeSigma）（德国）
- 丹纳赫集团 (Cytiva)（美国）
- 龙沙（瑞士）
- Sartorius AG（德国）
- Bio-Rad Laboratories, Inc.（美国）
- 康宁公司（美国）
- GE医疗（美国）
- BD (碧迪公司) (美国)
- Himedia 实验室 (印度)
- Promocell（德国）
- Sera Scandia A/S（丹麦）
- VWR International, LLC（美国）
- 智莱生物制品(上海)有限公司 (中国)
- Vitro Diagnostics Inc.（美国）
- Stemcell Technologies, Inc.（加拿大）
- Caisson Labs Inc.（美国）
- 高真生物株式会社（韩国）
- InvivoGen（美国）
- 富士控股美国公司（美国）
- Takara Bio Inc.（日本）
细胞培养基市场的最新发展
- 2024年9月，默克在德国、英国、中国和美国的全球细胞培养基生产基地获得了行业首个 EXCiPACT 医药辅助材料 cGMP 认证，确保生物制造中必需原材料的高安全性和质量标准
- 2024 年 9 月，Cytiva 在韩国仁川松岛开设了第一家创新中心，其中包括制造工厂和客户体验实验室。该中心旨在加强生物制药制造，旨在实现可持续的实践和合作，支持亚太地区生命科学行业的发展
- 2024 年 8 月，德国达姆施塔特默克集团生命科学业务 MilliporeSigma 以约 6 亿美元的价格完成了对 Mirus Bio 的收购。这一战略举措增强了 MilliporeSigma 的病毒载体生物加工能力，将 Mirus Bio 的先进转染试剂与其广泛的生物加工产品组合相结合，以支持细胞和基因治疗的进步
- 2024 年 7 月，默克在中国南通启动了第一条符合 GMP 标准的细胞培养基生产线，投资额为 728.4 万美元。该工厂提高了生产能力，支持了当地的生物制药制造商，并促进了新药和新疗法的更快获得，从而加强了默克对该地区的承诺
- 2023 年 7 月，A Sartorius 在波多黎各的 Yauco 工厂正式开设了一个新的 21,500 平方英尺的细胞培养基制造工厂。此次扩建增强了 Sartorius 生产符合监管要求的粉末培养基的能力，这对生物制药生产至关重要。该工厂旨在支持美洲地区日益增长的需求，并反映了 Sartorius 对本地运营的承诺。随着 2023 年春季开始生产，该工厂将继续加强 Sartorius 在生物制药行业的地位，并巩固其作为该公司在德国以外的首个制造基地的地位
- 2023 年 5 月，赛默飞世尔与 BRIN 建立合作伙伴关系，以增强印度尼西亚的研究能力，重点是促进当地研究人员在生命科学、生物技术和环境研究领域的科学创新与合作
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION
6.2.2 HIGH COST OF PRODUCTION
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATION AND PARTNERSHIPS
6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES
6.3.3 INNOVATIONS IN 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 COMPLEXITY OF MEDIA FORMULATION
6.4.2 INTENSE MARKET COMPETITION
7 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE
7.1 OVERVIEW
7.2 CHEMICALLY DEFINED MEDIA
7.3 CLASSICAL MEDIA
7.4 SERUM-FREE MEDIA
7.4.1 CHO MEDIA
7.4.2 HEK 293 MEDIA
7.4.3 CAR T-CELL MEDIA
7.4.4 VERO CELL MEDIA
7.4.5 BHK MEDIA
7.4.6 INSECT CELL MEDIA
7.4.7 SERUM-FREE CELL MEDIA
7.4.8 OTHER SERUM-FREE MEDIA
7.5 SPECIALTY MEDIA
7.6 STEM CELL MEDIA
7.6.1 MESENCHYMAL STEM CELLS (MSCS)
7.6.2 NEURAL STEM CELLS (NSCS)
7.6.3 EMBRYONIC STEM CELLS (ESCS)
7.6.4 BONE MARROW
7.6.5 OTHERS
7.7 LYSOGENY BROTH (LB)
7.8 CUSTOM MEDIA FORMULATION
7.9 OTHERS
8 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODIES
8.2.2 VACCINES PRODUCTION
8.2.3 OTHERS
8.3 DRUG SCREENING & DEVELOPMENT
8.4 DIAGNOSTICS
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING
8.5.1 STEM CELL AND GENE THERAPY
8.5.2 OTHERS
8.6 OTHERS
9 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOPHARMACEUTICAL COMPANIES
9.3 BIOTECHNOLOGY ORGANIZATIONS
9.4 ACADEMIC AND RESEARCH LABORATORIES
9.5 HOSPITALS
9.6 DIAGNOSTIC CENTERS
9.7 CELL BANKS
9.8 FORENSIC LABORATORIES
9.9 OTHERS
10 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 THIRD PARTY DISTRIBUTION
10.4 RETAILS SALES
11 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA-PACIFIC MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 DANAHER CORPORATION (CYTIVA)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 LONZA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 CORNING INCORPORATED
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT UPDATES
14.7 AJINOMOTO CO., INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AKRON BIOTECH
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT UPDATES
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CAISSON LABS INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT UPDATES
14.12 CELL APPLICATION, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT UPDATES
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 FUJIFILM HOLDINGS CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT UPDATES
14.15 HIMEDIA LABORATORIES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT UPDATES
14.16 KOH JIN-BIO CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT UPDATES
14.17 PAN-BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT UPDATES
14.18 PROMOCELL GMBH
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT UPDATES
14.19 SERA-SCANDIA A/S
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STEMCELL TECHNOLOGIES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TAKARA BIO INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表格列表
TABLE 1 GMP REQUIREMENTS
TABLE 2 SCOPE OF THE CURRENT DOCUMENT
TABLE 3 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 6 ASIA-PACIFIC CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 ASIA-PACIFIC CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 ASIA-PACIFIC SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 ASIA-PACIFIC LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 ASIA-PACIFIC CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 17 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 ASIA-PACIFIC DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 ASIA-PACIFIC DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 25 ASIA-PACIFIC BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 ASIA-PACIFIC BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 ASIA-PACIFIC ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 ASIA-PACIFIC HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 ASIA-PACIFIC CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 ASIA-PACIFIC FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 34 ASIA-PACIFIC DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 ASIA-PACIFIC RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 38 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 39 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 42 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 43 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 45 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 CHINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 CHINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 CHINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 CHINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 CHINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 CHINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 CHINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 53 CHINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 54 JAPAN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 JAPAN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 JAPAN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 57 JAPAN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 58 JAPAN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 59 JAPAN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 JAPAN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 61 JAPAN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 62 INDIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 63 INDIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 INDIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 INDIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 66 INDIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 INDIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 INDIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 69 INDIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 SOUTH KOREA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 SOUTH KOREA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 74 SOUTH KOREA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 SOUTH KOREA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 77 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 78 AUSTRALIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 AUSTRALIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 AUSTRALIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 AUSTRALIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 82 AUSTRALIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 83 AUSTRALIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 AUSTRALIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 85 AUSTRALIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 86 SINGAPORE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 SINGAPORE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 SINGAPORE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 SINGAPORE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 90 SINGAPORE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 SINGAPORE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 SINGAPORE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 93 SINGAPORE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 94 THAILAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 THAILAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 96 THAILAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 97 THAILAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 98 THAILAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 THAILAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 100 THAILAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 101 THAILAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 102 MALAYSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 MALAYSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 MALAYSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 MALAYSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 106 MALAYSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 MALAYSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 MALAYSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 109 MALAYSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 110 INDONESIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 INDONESIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 INDONESIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 INDONESIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 114 INDONESIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 115 INDONESIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 INDONESIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 117 INDONESIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 118 PHILIPPINES CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 119 PHILIPPINES SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 PHILIPPINES STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 PHILIPPINES CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 122 PHILIPPINES BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 PHILIPPINES REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 PHILIPPINES CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 125 PHILIPPINES CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 126 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
图片列表
FIGURE 1 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET FROM 2024 TO 2031
FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET IN 2024 AND 2031
FIGURE 15 DROC ANALYSIS
FIGURE 16 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, 2023
FIGURE 17 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 18 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023
FIGURE 21 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 22 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 23 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, 2023
FIGURE 25 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 26 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)
FIGURE 27 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 29 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 30 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 31 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SNAPSHOT
FIGURE 33 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
